Sinopharm Group Co. Ltd (X2S) — Capital Reinvestment Ratio
Sinopharm Group Co. Ltd (X2S) has a Capital Reinvestment Ratio of 0.01x as of December 2022, meaning it reinvests 0% of its operating cash flow (€52.39 Billion) in capital expenditures (€654.69 Million). See Sinopharm Group Co. Ltd (X2S) balance sheet quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Sinopharm Group Co. Ltd Capital Reinvestment Ratio (2013–2025)
This chart tracks Sinopharm Group Co. Ltd's Capital Reinvestment Ratio across 13 annual periods. Check Sinopharm Group Co. Ltd (X2S) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Sinopharm Group Co. Ltd (2013–2025)
Year-by-year Capital Reinvestment Ratio for Sinopharm Group Co. Ltd from 2013 to 2025. For live market cap and broader valuation context, see how much is Sinopharm Group Co. Ltd worth.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.11x | €14.14 Billion | €1.62 Billion | ▼ -32.9% |
| 2024 | 0.17x | €11.55 Billion | €1.97 Billion | ▲ +25.3% |
| 2023 | 0.14x | €17.17 Billion | €2.34 Billion | ▲ +34.1% |
| 2022 | 0.10x | €20.96 Billion | €2.13 Billion | ▼ -54.5% |
| 2021 | 0.22x | €9.31 Billion | €2.07 Billion | ▲ +31.0% |
| 2020 | 0.17x | €11.15 Billion | €1.90 Billion | ▲ +44.8% |
| 2019 | 0.12x | €18.78 Billion | €2.21 Billion | ▼ -86.8% |
| 2018 | 0.89x | €3.65 Billion | €3.24 Billion | ▲ +34.2% |
| 2017 | 0.66x | €3.21 Billion | €2.12 Billion | ▲ +348.6% |
| 2016 | 0.15x | €9.26 Billion | €1.36 Billion | ▲ +93.6% |
| 2015 | 0.08x | €13.41 Billion | €1.02 Billion | ▼ -70.8% |
| 2014 | 0.26x | €5.56 Billion | €1.45 Billion | ▲ +14.2% |
| 2013 | 0.23x | €4.94 Billion | €1.13 Billion | — |